No verified evidence links Gracie Abrams to any weight-loss drug, yet photographs of the singer reportedly drew millions of views and fuelled Ozempic speculation. The claims rest on photographs alone, yet they have renewed scrutiny of GLP-1 drugs and their risks.

The photographs were taken at the WYouth launch party on October 26 at Thai Diner in Nolita. On October 27, the user @transleytanked posted them on X, and users debated whether her lean frame reflected lighting and camera angles or raised concern for her well-being.

Ozempic is approved for type 2 diabetes, not weight loss, a Columbia Surgery physician noted. Wegovy, which contains the same drug, semaglutide, is the version approved for weight loss.

Online Debate Over Appearance

One user said Ozempic should be taken away from Hollywood, while others said she looked normal and urged people to stop commenting on women's bodies. Abrams became a major trending topic on X.

Users also pointed to Jenna Ortega, Ariana Grande, Alexa Demie and Demi Moore, though none has acknowledged the Ozempic speculation. Grande addressed the buzz around her physique, saying she was healthier than she had ever been.

How GLP-1 Drugs Work

GLP-1 drugs such as Ozempic mimic a hormone the gut releases after eating, according to Harvard Health. They slow stomach emptying and signal fullness to the brain, which reduces food intake.

Clinical trials have found that some GLP-1-based weight-management medicines can produce average weight losses of around 10 to 15 per cent or more, depending on the drug, dose and duration of treatment. Even a 5 per cent to 10 per cent reduction can improve metabolic health and lower blood pressure.

GLP-1 drugs are helping shift obesity from a personal failure to a treatable medical condition, the physician said. However, side effects such as nausea, reflux and cramping can limit use, and cost and insurance coverage remain barriers.

It is unknown how many users are not medically obese, with some taking the drugs for just 10 or 15 pounds. The physician called such use 'fashionable', although GLP-1 medicines have been used to treat diabetes for years. Their longer-term effects when used for weight management continue to be studied.

Read more

Risks and Unanswered Questions

Common side effects include nausea, vomiting, diarrhoea, constipation and abdominal discomfort. Ozempic carries a boxed warning for thyroid C-cell tumours seen in rodents, though it is not known whether this occurs in people.

Persistent nausea or vomiting can lead to dehydration, kidney problems or malnutrition in some cases. Pancreatitis and gallbladder problems are possible, though the pancreatitis risk appears low, and some reports suggest rapid weight loss may reduce muscle mass.

Muscle loss is a particular concern for older adults, who may be at higher risk of frailty and falls. Doctors may advise increasing protein intake.

Dr Chika Anekwe, obesity medicine clinical director at the Massachusetts General Hospital Weight Center, said gastrointestinal side effects are usually temporary and manageable. Doctors typically start with a low dose and increase it gradually.

Anyone taking or considering a GLP-1 drug is advised to discuss the risks with a doctor. GLP-1 medicines are generally not recommended during pregnancy, and their use during breastfeeding requires medical advice because safety data are limited.

People with severe gastroparesis may be advised against using certain medicines in this class, and those with inflammatory bowel disease should discuss individual risks with their healthcare professional.

The FDA has warned about compounded GLP-1 drugs because of reports of harmful side effects. The agency does not check them for safety, effectiveness or quality.

The drugs generally require lifelong use, and stopping often leads to weight regain. Ozempic costs about $1,200 (£900) a month, depending on the dose and insurance.

The claims about Abrams remain speculation based on photographs. No available report confirms she has used any weight-loss drug, and the debate has centred on appearance rather than verified health details.

Read more